Kintor, Fosun partner to commercialise proxalutamide in India and Africa
The collaboration will focus on the emergency use authorisation, promotion, and sale of proxalutamide for the treatment of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Jul 21
The collaboration will focus on the emergency use authorisation, promotion, and sale of proxalutamide for the treatment of…
14 Jul 21
The sale is part of Sanofi’s strategy to simplify its consumer healthcare portfolio and advance its growth
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Jul 21
WHO announced its decision to authorise Sinovac's CoronaVac for Emergency Use, following the review by SAGE
13 Jul 21
InnoCare is expected to receive a $125m upfront payment in addition to potential milestone payments and tiered royalties
12 Jul 21
With the acquisition, PMI will get access to technology and pharmaceutical development expertise to deliver complex inhaled therapies
12 Jul 21
The approval of Kerendia is based on results of Phase 3 FIDELIO-DKD trial and follows priority review designation…
09 Jul 21
Pfizer and BioNTech believe that a third dose may be needed within six to 12 months after the…
08 Jul 21
Vyxeos belongs to the antineoplastics class of medicines, developed using the company’s CombiPlex technology platform
07 Jul 21
The announcement follows competition clearances in the US, Japan and other countries, pending regulatory approval in the UK
06 Jul 21
Lumevoq is authorised to treat patients with vision loss due to LHON caused by a mutation in the…